Calamos Convertible Equity Alternative ETF
CVRT · ETF
About CVRT
- Issuer
- Calamos
- Expense ratio
- 0.69%
- Assets under management
- $37.71M
- Inception
- Oct 4, 2023
- Asset class
- Fixed Income
- Website
- calamos.com
CVRT key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 6.11K
- Volume
- 1.99K
- Open price
- $43.07
- High today
- $43.43
- Low today
- $43.08
- 52 Week high
- $54.09
- 52 Week low
- $35.46
Calamos Convertible Equity Alternative ETF (CVRT) at a glance
Calamos Convertible Equity Alternative ETF (CVRT) last traded at $43.28, with a price-to-earnings ratio of 0.00.
Today the fund has traded between $43.08 and $43.43. The current price is 0.5% above the day's low and 0.4% below its high.
Volume so far is 1.99K shares, below the average of 6.11K shares a day.
Over the past year Calamos Convertible Equity Alternative ETF has ranged from $35.46 to $54.09, and now sits 42% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.